Drug Trial Radar · NCT06797401
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Jan 28, 2025
Primary completion
May 31, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Ribocure Pharmaceuticals ABIndustry
- Sponsor type
- Industry
- First posted
- Jan 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if drug RBD5044 works to treat mixed dyslipidemia in adults. It will also learn about the safety of drug RBD5044. The main questions it aims to answer are: Does drug RBD5044 reduce the triglyceride levels? What medical problems may participants experience when taking drug RBD5044? Researchers will compare drug RBD5044 to a placebo to see if drug RBD5044 works to treat mixed dyslipidemia. Participants will: Receive RBD5044 or placebo twice during the trial (Day 1 and Day 84). Visit the clinic 11 times during 12 months (visit every 4-8 weeks) for checkups and tests.
Conditions
- Dyslipidemias
Interventions
RBD5044Drug
RBD5044, active drug.
PlaceboDrug
Placebo that is identical in appearance and volume to the doses of active IMP.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in triglyceride (TG) levels at week 16Time frame: From baseline until end week 16
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Linden Sp.
Krakow, Poland · Recruiting
Balsam Medica Sp.
Warsaw, Poland · Recruiting
Lunds Universitetssjukhus
Lund, Sweden · Recruiting
Ribocure Clinic/Ribocure Pharmaceuticals AB
Mölndal, Sweden · Recruiting
AkardoMedSite
Stockholm, Sweden · Recruiting
Akademiska Sjukhuset Uppsala
Uppsala, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.